Risk factors in the treatment of rheumatoid arthritis with parenteral gold.
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006052:Gold Sodium Thiomalate / Q000009:adverse effects*; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000139:chemically induced; D012189:Retrospective Studies; D012871:Skin Diseases / Q000139:chemically induced
D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D006052:Gold Sodium Thiomalate